logo
International Conference and Exhibition on
Biowaivers and Biosimilars
September 10-12, 2012 Hilton San Antonio Airport, USA
button1
button2
Biosimilars-2012

    Previous Events
     
     
    Thank you to all the conference attendees for making the Biosimilars-2012 conference a memorable experience
     

    We are glad you were able to join us for the International Conference and Exhibition on Biowaivers & Biosimilars .
     
    • We hope that you enjoyed the caliber of presentations and our hospitality. Our special thanks to our Editorial Board Members for providing advice on the agenda, and in supporting the conference.

    •Mark your calendars for the 2013 conference at Hilton Northbrook/Chicago during September 23-25, 2013.
     
    We certainly enjoyed having you and look forward to seeing you again!

    Biosimilars-2012 Organizing Committee
     
    Submit your manuscript now »»
    All accepted abstracts have been indexed in OMICS Group Journal of Bioequivalence & Bioavailability as a special issue: http://www.omicsonline.org/ArchiveJBB/0975-0851-Biosimilars-2012_KeyNote.php
    All accepted abstracts have been indexed in OMICS Group Journal of Bioequivalence & Bioavailability as a special issue. We would like to invite you to submit your manuscript to be considered for publication in the Journal. In accordance with standard procedures for the journal, all papers will be peer reviewed prior to the Editor making a final decision on suitability for publication.
    The Journal of Bioequivalence & Bioavailabilty is an international, peer-reviewed journal publishing an overview of human research on substance abuse which includes the contents geared towards biowaivers and biosimilars studies.
     
    The Bioequivalence & Bioavailability is using online manuscript submission, review and tracking systems of online submission for quality and quick review processing. Review processing is performed by the Editorial Board members of the Bioequivalence & Bioavailability or outside experts.

    A manuscript number will be mailed to the corresponding author on same day or within 72 hours.
     
  • Please ensure that your manuscript complies with the Journal guide for authors available at http://www.omicsonline.org/InstructionsForAuthorsJBB.php
  • Submit online at
  • http://www.omicsonline.org/submission/
     
     
    Final Program
    Final  Program
    Renowned Speakers
    speker Carmine Lanni
    Bioanalytical Development Services, USA

    speker Veysel Kayser
    MIT, USA

    speker Paul A. Calvo
    Sterne, Kessler, Goldstein & Fox, USA

    speker Brian R. Dorn
    Barnes & Thornburg LLP, USA

    speker Ben Kaspar
    MMS Holdings Inc., USA

    speker William Velander
    University of Nebraska, USA

    speker Parastoo Azadi
    University of Georgia, USA

    speker Bryan J. Vogel
    Robins, Kaplan, Miller & Ciresi L.L.P, USA

    speker Laszlo Endrenyi
    University of Toronto, Canada

    speker Leandro Mieravilla
    Biosimilar-Boitech Global Expert, Canada

    speker Michael D. McLean
    PlantForm Corporation, Canada

    speker David Goodall
    Paraytec Limited, UK

    speker Joachim Stellmach
    European Patent Office, Germany

    speker Faud Fares
    University of Haifa, Israel

    speker Lisa J. Murray
    Absorption Systems, USA

    speker Kelly S. Colletti
    Charles River Preclinical Services, USA

    speker Indu Javeri
    CuriRx Inc, USA

    speker Amal Ali Elkordy
    University of Sunderland, UK

    speker Melody Sauerborn
    ADA-In Vivo, Netherlands

    speker Gustavo Helguera
    University of Buenos Aires, Argentina

    speker Su Chen
    Chainon Neurotrophin Biotechnology Inc, USA

    speker Hong Zhao
    Enzon Pharmaceuticals, USA

    speker Xing Wang
    Array Bridge Inc, USA

    speker Ming Wang
    Gan & Lee Pharmaceuticals, China

    Popular Journals
    Media Partner
    images
     
     
    follow
    Conference Secretariat: Biosimilars-2012, OMICS Group Conferences
    5716 Corsa Ave., Suite 110, Westlake, Los Angeles, CA 91362-7354, USA
    Tel: +1-650-268-9744 | Fax: +1-650-618-1414
    Toll free: 1-800-216-6499 (USA & Canada), 1-800-651-097 (Australia), 0805-080048 (Europe)
    Email: biosimilars2012@omicsgroup.com
    Operated by: Editors- Journal of Bioanalysis and Biomedicine, Journal of Bioequivalence and Bioavailability, Pharmaceutica Analytica Acta
    The Organizers reserve the rights to make changes and adjustment to the information in this website
    Copyright 2008-2012 OMICS Group - All rights reserved
    Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version